PetSmart kicked off the trend of offering veterinary services in retail stores back in 1994. Now they're revolutionizing the market again with an independent business ownership model that allows veterinarians to open their own AAHA-accredited practice inside a PetSmart location.
After receiving adverse reports involving five animals, Australia-based Jurox Animal Health voluntarily recalled two lots of the widely used intravenous injectable anesthetic Alfaxan unpreserved last week, according to the US Food and Drug Administration (FDA). The reason for the recall: The presence of aluminum phosphate precipitate, which, when injected, presents a possible risk of blood vessel inflammation and formation of potentially life-threatening blood clots.
Okay, maybe just one needle every three months. But one shot every 90 days sure beats daily insulin injections, if promising new research out of Purdue University bears fruit. Last week, the school released the preliminary findings of a new study: The first minimally invasive therapy to successfully reverse Type 1 diabetes within 24 hours and maintain insulin independence for at least 90 days in test subjects.
“Veterinarians who want to report suspected animal abuse often encounter a bureaucratic runaround,” says Phil Arkow. Arkow hopes that the recent launch of a free online National Directory of Abuse Investigation Agencies will help. Arkow is Coordinator of the National Link Coalition, a multidisciplinary, collaborative initiative formed in 2008 to raise awareness of the connection between animal abuse, child abuse, and domestic violence. It’s based on the idea that violence begets violence, and that when animal cruelty or neglect exists in a home, chances are that children, domestic partners, or elderly family members are being hurt, too.
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.